 Akira Miyake
Concepts (824)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Individuality | 20 | 2023 | 155 | 3.430 |
Why?
| | Executive Function | 13 | 2019 | 440 | 2.140 |
Why?
| | Memory, Short-Term | 11 | 2021 | 249 | 1.820 |
Why?
| | Cognition | 17 | 2023 | 1146 | 1.590 |
Why?
| | Attention | 15 | 2023 | 426 | 1.490 |
Why?
| | Reading | 8 | 2024 | 135 | 1.480 |
Why?
| | Evoked Potentials | 3 | 2024 | 126 | 1.330 |
Why?
| | Aptitude | 6 | 2017 | 36 | 1.150 |
Why?
| | Self-Control | 3 | 2023 | 53 | 1.070 |
Why?
| | Electroencephalography | 3 | 2024 | 430 | 0.920 |
Why?
| | Ego | 3 | 2023 | 10 | 0.890 |
Why?
| | Memory | 8 | 2016 | 248 | 0.830 |
Why?
| | Comprehension | 3 | 2024 | 171 | 0.750 |
Why?
| | Self Concept | 2 | 2016 | 249 | 0.730 |
Why?
| | Reaction Time | 10 | 2018 | 412 | 0.670 |
Why?
| | Universities | 2 | 2021 | 433 | 0.660 |
Why?
| | Psychomotor Performance | 6 | 2018 | 309 | 0.650 |
Why?
| | Pessimism | 1 | 2019 | 9 | 0.620 |
Why?
| | Internal-External Control | 2 | 2016 | 70 | 0.600 |
Why?
| | Task Performance and Analysis | 3 | 2016 | 183 | 0.590 |
Why?
| | Anxiety | 2 | 2016 | 1031 | 0.590 |
Why?
| | Psycholinguistics | 2 | 2017 | 20 | 0.560 |
Why?
| | Language | 4 | 2024 | 292 | 0.510 |
Why?
| | Mental Recall | 7 | 2008 | 201 | 0.500 |
Why?
| | Students | 3 | 2022 | 624 | 0.490 |
Why?
| | Orientation | 3 | 2002 | 48 | 0.480 |
Why?
| | Neuropsychological Tests | 14 | 2017 | 1022 | 0.470 |
Why?
| | Epidermal Growth Factor | 5 | 1998 | 175 | 0.470 |
Why?
| | Cerebral Cortex | 3 | 2017 | 433 | 0.440 |
Why?
| | Cooperative Behavior | 2 | 2016 | 445 | 0.440 |
Why?
| | Humans | 107 | 2024 | 136765 | 0.430 |
Why?
| | Space Perception | 4 | 2016 | 80 | 0.410 |
Why?
| | Verbal Behavior | 2 | 2004 | 40 | 0.410 |
Why?
| | Female | 76 | 2024 | 72795 | 0.400 |
Why?
| | Learning | 2 | 2022 | 406 | 0.400 |
Why?
| | Brain | 5 | 2024 | 2664 | 0.390 |
Why?
| | Interpersonal Relations | 1 | 2016 | 396 | 0.390 |
Why?
| | Cognition Disorders | 4 | 2023 | 495 | 0.390 |
Why?
| | Racism | 1 | 2015 | 135 | 0.390 |
Why?
| | Ether-A-Go-Go Potassium Channels | 2 | 2009 | 6 | 0.370 |
Why?
| | Young Adult | 17 | 2024 | 13127 | 0.360 |
Why?
| | Male | 56 | 2024 | 67311 | 0.360 |
Why?
| | Physics | 1 | 2010 | 17 | 0.350 |
Why?
| | Cephalosporins | 6 | 1992 | 47 | 0.350 |
Why?
| | Cues | 4 | 2016 | 313 | 0.340 |
Why?
| | Social Values | 1 | 2010 | 36 | 0.340 |
Why?
| | Achievement | 1 | 2010 | 57 | 0.340 |
Why?
| | Frontal Lobe | 3 | 2008 | 149 | 0.320 |
Why?
| | Chromans | 3 | 1994 | 25 | 0.320 |
Why?
| | Verbal Learning | 2 | 2002 | 60 | 0.320 |
Why?
| | Adult | 38 | 2024 | 37631 | 0.310 |
Why?
| | Phospholipases A | 3 | 1994 | 102 | 0.310 |
Why?
| | Pattern Recognition, Visual | 3 | 2015 | 101 | 0.310 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2009 | 188 | 0.300 |
Why?
| | Heart Defects, Congenital | 4 | 2022 | 833 | 0.300 |
Why?
| | Receptors, Cholecystokinin | 4 | 1997 | 8 | 0.300 |
Why?
| | Adolescent | 28 | 2024 | 21382 | 0.290 |
Why?
| | Models, Psychological | 4 | 2016 | 302 | 0.290 |
Why?
| | Problem Solving | 3 | 2008 | 152 | 0.280 |
Why?
| | Goals | 3 | 2015 | 169 | 0.280 |
Why?
| | Prolactin | 7 | 2000 | 97 | 0.270 |
Why?
| | Potassium Channels | 4 | 2003 | 151 | 0.270 |
Why?
| | Transforming Growth Factor alpha | 3 | 1996 | 57 | 0.260 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2023 | 413 | 0.260 |
Why?
| | ErbB Receptors | 5 | 1996 | 613 | 0.260 |
Why?
| | Visual Perception | 4 | 2002 | 160 | 0.250 |
Why?
| | Pyridazines | 2 | 1997 | 56 | 0.250 |
Why?
| | Gene-Environment Interaction | 3 | 2017 | 190 | 0.250 |
Why?
| | Thinking | 2 | 2021 | 65 | 0.250 |
Why?
| | Music | 1 | 2006 | 46 | 0.240 |
Why?
| | Decidua | 3 | 1997 | 24 | 0.240 |
Why?
| | Receptors, Serotonin | 4 | 2000 | 34 | 0.240 |
Why?
| | Fallopian Tubes | 3 | 1999 | 31 | 0.240 |
Why?
| | Molecular Sequence Data | 15 | 2008 | 2894 | 0.240 |
Why?
| | Hypoplastic Left Heart Syndrome | 2 | 2018 | 121 | 0.230 |
Why?
| | Receptors, Interleukin | 2 | 1995 | 45 | 0.230 |
Why?
| | Psychological Theory | 2 | 2016 | 97 | 0.230 |
Why?
| | Growth Substances | 4 | 1998 | 147 | 0.230 |
Why?
| | Pituitary Gland | 5 | 1997 | 148 | 0.230 |
Why?
| | Talc | 1 | 2024 | 9 | 0.220 |
Why?
| | Powders | 1 | 2024 | 41 | 0.220 |
Why?
| | Semantics | 2 | 2024 | 92 | 0.220 |
Why?
| | Twins, Dizygotic | 4 | 2017 | 175 | 0.220 |
Why?
| | Gene Expression | 7 | 2000 | 1500 | 0.220 |
Why?
| | Insecticides | 1 | 2024 | 38 | 0.210 |
Why?
| | Research Design | 4 | 2021 | 1127 | 0.210 |
Why?
| | Twins, Monozygotic | 4 | 2017 | 203 | 0.210 |
Why?
| | RNA, Messenger | 15 | 2000 | 2831 | 0.210 |
Why?
| | Adolescent Development | 2 | 2016 | 86 | 0.200 |
Why?
| | Potassium Channels, Voltage-Gated | 2 | 2002 | 50 | 0.200 |
Why?
| | Phenols | 2 | 1994 | 97 | 0.200 |
Why?
| | Long QT Syndrome | 2 | 2014 | 70 | 0.200 |
Why?
| | Nerve Tissue Proteins | 3 | 2008 | 595 | 0.190 |
Why?
| | Anti-Asthmatic Agents | 2 | 1997 | 393 | 0.190 |
Why?
| | Pseudohypoparathyroidism | 1 | 2001 | 3 | 0.190 |
Why?
| | Laryngismus | 1 | 2001 | 9 | 0.190 |
Why?
| | Field Dependence-Independence | 1 | 2001 | 5 | 0.180 |
Why?
| | Blood Alcohol Content | 1 | 2021 | 5 | 0.180 |
Why?
| | Animals | 50 | 2009 | 36847 | 0.180 |
Why?
| | Blotting, Northern | 8 | 1998 | 200 | 0.180 |
Why?
| | Ovarian Neoplasms | 4 | 1999 | 562 | 0.180 |
Why?
| | Japan | 6 | 2024 | 115 | 0.170 |
Why?
| | Reproducibility of Results | 4 | 2016 | 3265 | 0.170 |
Why?
| | Saccades | 2 | 2015 | 40 | 0.170 |
Why?
| | Chemotactic Factors | 2 | 1997 | 56 | 0.170 |
Why?
| | Chemokines, CXC | 2 | 1997 | 70 | 0.170 |
Why?
| | Enzyme Inhibitors | 3 | 2010 | 839 | 0.170 |
Why?
| | Cell Line | 11 | 2003 | 2838 | 0.160 |
Why?
| | Telencephalon | 1 | 1999 | 16 | 0.160 |
Why?
| | 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1996 | 21 | 0.160 |
Why?
| | Amino Acid Sequence | 11 | 2008 | 2138 | 0.160 |
Why?
| | Polymerase Chain Reaction | 8 | 2001 | 1059 | 0.160 |
Why?
| | Interleukin-6 | 4 | 1997 | 778 | 0.150 |
Why?
| | Surveys and Questionnaires | 5 | 2019 | 5742 | 0.150 |
Why?
| | Scimitar Syndrome | 1 | 2018 | 9 | 0.150 |
Why?
| | Hypothalamus | 2 | 1996 | 153 | 0.150 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 1997 | 382 | 0.150 |
Why?
| | Heterotaxy Syndrome | 1 | 2018 | 14 | 0.150 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2018 | 30 | 0.140 |
Why?
| | Twins | 4 | 2014 | 242 | 0.140 |
Why?
| | Emotions | 1 | 2023 | 545 | 0.140 |
Why?
| | Rats | 18 | 2000 | 5639 | 0.140 |
Why?
| | Mice | 20 | 2009 | 17757 | 0.140 |
Why?
| | Guidelines as Topic | 1 | 2000 | 275 | 0.140 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 4 | 1999 | 182 | 0.130 |
Why?
| | Child Development | 2 | 2012 | 464 | 0.130 |
Why?
| | Menstrual Cycle | 2 | 1995 | 133 | 0.130 |
Why?
| | Cystadenocarcinoma | 1 | 1996 | 4 | 0.130 |
Why?
| | CA-125 Antigen | 1 | 1996 | 14 | 0.130 |
Why?
| | Fibroblast Growth Factors | 1 | 1998 | 171 | 0.130 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 1993 | 150 | 0.130 |
Why?
| | Follicle Stimulating Hormone | 8 | 1997 | 244 | 0.130 |
Why?
| | Arteriovenous Malformations | 1 | 1996 | 27 | 0.130 |
Why?
| | Monosaccharide Transport Proteins | 1 | 1996 | 51 | 0.130 |
Why?
| | Estradiol | 4 | 1996 | 518 | 0.130 |
Why?
| | Calcium | 7 | 2001 | 1197 | 0.120 |
Why?
| | Intelligence | 5 | 2011 | 123 | 0.120 |
Why?
| | Mice, Inbred ICR | 5 | 1997 | 119 | 0.120 |
Why?
| | Random Allocation | 3 | 2018 | 353 | 0.120 |
Why?
| | Thromboxane-A Synthase | 1 | 1995 | 3 | 0.120 |
Why?
| | Motion Pictures | 1 | 2016 | 19 | 0.120 |
Why?
| | Alcoholic Intoxication | 1 | 2016 | 68 | 0.120 |
Why?
| | Genetic Phenomena | 1 | 2015 | 8 | 0.120 |
Why?
| | Cloning, Molecular | 6 | 2003 | 534 | 0.120 |
Why?
| | Educational Measurement | 2 | 2010 | 280 | 0.120 |
Why?
| | Sample Size | 1 | 2016 | 125 | 0.120 |
Why?
| | Base Sequence | 6 | 2001 | 2179 | 0.120 |
Why?
| | Heterocyclic Compounds | 2 | 1992 | 20 | 0.120 |
Why?
| | Association | 1 | 2015 | 12 | 0.120 |
Why?
| | Dangerous Behavior | 1 | 2015 | 19 | 0.120 |
Why?
| | Adipose Tissue | 2 | 1997 | 630 | 0.110 |
Why?
| | Genotype | 2 | 2011 | 1914 | 0.110 |
Why?
| | Arousal | 1 | 2015 | 155 | 0.110 |
Why?
| | Dextrocardia | 1 | 2014 | 3 | 0.110 |
Why?
| | Vagina | 1 | 1996 | 186 | 0.110 |
Why?
| | Pregnancy, Animal | 1 | 1994 | 52 | 0.110 |
Why?
| | 3T3 Cells | 1 | 1994 | 163 | 0.110 |
Why?
| | Phonetics | 2 | 2006 | 36 | 0.110 |
Why?
| | NAV1.5 Voltage-Gated Sodium Channel | 1 | 2014 | 13 | 0.110 |
Why?
| | Psychological Tests | 2 | 2008 | 140 | 0.110 |
Why?
| | Substance-Related Disorders | 2 | 2017 | 1069 | 0.110 |
Why?
| | Transplantation, Heterologous | 1 | 1994 | 194 | 0.110 |
Why?
| | Neoplasm Transplantation | 1 | 1994 | 257 | 0.110 |
Why?
| | Alternative Splicing | 2 | 2000 | 229 | 0.110 |
Why?
| | Genitalia, Female | 1 | 2014 | 38 | 0.110 |
Why?
| | Stents | 1 | 2018 | 527 | 0.110 |
Why?
| | In Vitro Techniques | 4 | 1997 | 1089 | 0.110 |
Why?
| | Electrocardiography | 2 | 2014 | 629 | 0.110 |
Why?
| | Carrageenan | 1 | 1993 | 8 | 0.110 |
Why?
| | Depression | 2 | 2015 | 1396 | 0.110 |
Why?
| | Macrophages, Peritoneal | 1 | 1994 | 94 | 0.110 |
Why?
| | Tumor Cells, Cultured | 9 | 2000 | 953 | 0.110 |
Why?
| | Exons | 1 | 1995 | 351 | 0.110 |
Why?
| | Saliva | 1 | 1995 | 242 | 0.110 |
Why?
| | Ethanol | 1 | 2018 | 606 | 0.100 |
Why?
| | Recombinant Proteins | 5 | 1999 | 1350 | 0.100 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 1993 | 350 | 0.100 |
Why?
| | Peptides | 2 | 1996 | 980 | 0.100 |
Why?
| | Dinoprostone | 1 | 1994 | 191 | 0.100 |
Why?
| | Pituitary Gland, Anterior | 5 | 1996 | 38 | 0.100 |
Why?
| | Uterus | 4 | 1999 | 215 | 0.100 |
Why?
| | Wolff-Parkinson-White Syndrome | 1 | 2013 | 19 | 0.100 |
Why?
| | Adipocytes | 1 | 1994 | 222 | 0.100 |
Why?
| | Data Collection | 1 | 2016 | 668 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 8 | 2000 | 2052 | 0.100 |
Why?
| | Phenotype | 5 | 2017 | 3189 | 0.100 |
Why?
| | Ventricular Fibrillation | 1 | 2013 | 60 | 0.100 |
Why?
| | Sequence Homology, Amino Acid | 6 | 2002 | 385 | 0.100 |
Why?
| | Sincalide | 4 | 1997 | 5 | 0.100 |
Why?
| | Motivation | 2 | 2014 | 567 | 0.100 |
Why?
| | Impulsive Behavior | 1 | 2014 | 149 | 0.100 |
Why?
| | Electrodes, Implanted | 1 | 2013 | 109 | 0.100 |
Why?
| | Tissue Distribution | 5 | 2003 | 330 | 0.100 |
Why?
| | Equol | 1 | 2012 | 5 | 0.100 |
Why?
| | Immunohistochemistry | 5 | 1997 | 1733 | 0.100 |
Why?
| | Phytoestrogens | 1 | 2012 | 17 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 4 | 2008 | 3555 | 0.090 |
Why?
| | Skin Aging | 1 | 2012 | 19 | 0.090 |
Why?
| | In Situ Hybridization | 5 | 2001 | 316 | 0.090 |
Why?
| | Cells, Cultured | 10 | 2001 | 4191 | 0.090 |
Why?
| | Rats, Wistar | 8 | 1997 | 455 | 0.090 |
Why?
| | Transfection | 4 | 2003 | 941 | 0.090 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1997 | 1242 | 0.090 |
Why?
| | Binding, Competitive | 4 | 2000 | 202 | 0.090 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2014 | 201 | 0.090 |
Why?
| | DNA, Complementary | 5 | 2001 | 271 | 0.090 |
Why?
| | Biomarkers, Tumor | 2 | 1996 | 1272 | 0.090 |
Why?
| | Alcohol Drinking | 1 | 2018 | 820 | 0.090 |
Why?
| | Longitudinal Studies | 6 | 2017 | 2829 | 0.090 |
Why?
| | Glucose | 1 | 1996 | 1019 | 0.090 |
Why?
| | Factor Analysis, Statistical | 3 | 2011 | 283 | 0.090 |
Why?
| | Hyponatremia | 1 | 2011 | 42 | 0.090 |
Why?
| | Reversal Learning | 1 | 2010 | 10 | 0.090 |
Why?
| | Placenta | 2 | 1997 | 749 | 0.090 |
Why?
| | Stereotyping | 1 | 2010 | 45 | 0.080 |
Why?
| | Structure-Activity Relationship | 5 | 1997 | 570 | 0.080 |
Why?
| | Temperament | 1 | 2010 | 46 | 0.080 |
Why?
| | Pituitary Function Tests | 1 | 1989 | 2 | 0.080 |
Why?
| | Beclin-1 | 1 | 2009 | 11 | 0.080 |
Why?
| | Autonomic Nervous System | 1 | 2010 | 75 | 0.080 |
Why?
| | Sodium | 1 | 2011 | 216 | 0.080 |
Why?
| | Postmenopause | 1 | 2012 | 365 | 0.080 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2010 | 80 | 0.080 |
Why?
| | Pregnancy | 11 | 2022 | 6726 | 0.080 |
Why?
| | Bayes Theorem | 2 | 2022 | 404 | 0.080 |
Why?
| | Social Environment | 2 | 2009 | 295 | 0.080 |
Why?
| | Microbial Sensitivity Tests | 6 | 1992 | 357 | 0.080 |
Why?
| | Ion Channel Gating | 3 | 2002 | 90 | 0.080 |
Why?
| | Maze Learning | 1 | 2009 | 103 | 0.080 |
Why?
| | Defibrillators, Implantable | 1 | 2013 | 315 | 0.080 |
Why?
| | Mice, Inbred DBA | 1 | 2009 | 200 | 0.080 |
Why?
| | Phospholipases A2 | 3 | 1994 | 80 | 0.080 |
Why?
| | Drug Design | 1 | 2010 | 167 | 0.080 |
Why?
| | Patch-Clamp Techniques | 5 | 2003 | 286 | 0.080 |
Why?
| | Models, Neurological | 1 | 2011 | 242 | 0.080 |
Why?
| | Fontan Procedure | 1 | 2011 | 180 | 0.080 |
Why?
| | Epilepsy | 1 | 2013 | 331 | 0.080 |
Why?
| | Motor Skills | 1 | 2009 | 97 | 0.080 |
Why?
| | Gene Expression Regulation | 2 | 1995 | 2605 | 0.070 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 1994 | 1396 | 0.070 |
Why?
| | Atrial Fibrillation | 1 | 2013 | 388 | 0.070 |
Why?
| | Heart Failure | 1 | 2022 | 2231 | 0.070 |
Why?
| | Time Factors | 9 | 2011 | 6808 | 0.070 |
Why?
| | Gonadotropin-Releasing Hormone | 6 | 1997 | 212 | 0.070 |
Why?
| | Psoriasis | 1 | 2009 | 102 | 0.070 |
Why?
| | Blastocyst | 2 | 2001 | 48 | 0.070 |
Why?
| | Speech Perception | 2 | 2002 | 82 | 0.070 |
Why?
| | Amyloid beta-Peptides | 1 | 2010 | 220 | 0.070 |
Why?
| | Growth Inhibitors | 2 | 1997 | 43 | 0.070 |
Why?
| | Age Factors | 5 | 2016 | 3284 | 0.070 |
Why?
| | Diagnosis, Differential | 4 | 2013 | 1481 | 0.070 |
Why?
| | Analysis of Variance | 2 | 2004 | 1316 | 0.070 |
Why?
| | Natriuretic Peptide, Brain | 2 | 2022 | 99 | 0.070 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2009 | 267 | 0.070 |
Why?
| | Infant, Newborn | 4 | 2022 | 6032 | 0.070 |
Why?
| | RNA, Neoplasm | 2 | 1998 | 82 | 0.070 |
Why?
| | Paraventricular Hypothalamic Nucleus | 2 | 1997 | 32 | 0.060 |
Why?
| | Trans-Activators | 3 | 2000 | 398 | 0.060 |
Why?
| | Computer Simulation | 1 | 2011 | 973 | 0.060 |
Why?
| | Conduct Disorder | 1 | 2009 | 201 | 0.060 |
Why?
| | Orbital Neoplasms | 1 | 2006 | 24 | 0.060 |
Why?
| | Kinetics | 7 | 1997 | 1664 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2003 | 975 | 0.060 |
Why?
| | Guinea Pigs | 2 | 1997 | 158 | 0.060 |
Why?
| | Chromosome Mapping | 2 | 1999 | 523 | 0.060 |
Why?
| | Social Behavior | 1 | 2009 | 284 | 0.060 |
Why?
| | Arachidonic Acid | 3 | 2003 | 120 | 0.060 |
Why?
| | Luteinizing Hormone | 6 | 1997 | 185 | 0.060 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2008 | 220 | 0.060 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2006 | 71 | 0.060 |
Why?
| | Endometrial Neoplasms | 2 | 1998 | 199 | 0.060 |
Why?
| | Epithelium | 3 | 1996 | 311 | 0.060 |
Why?
| | Pituitary Neoplasms | 3 | 2000 | 190 | 0.060 |
Why?
| | Benzodiazepines | 2 | 1997 | 153 | 0.060 |
Why?
| | Protein-Tyrosine Kinases | 3 | 1997 | 434 | 0.060 |
Why?
| | Blotting, Southern | 2 | 1995 | 72 | 0.060 |
Why?
| | Mice, Knockout | 2 | 2009 | 3008 | 0.060 |
Why?
| | Child | 13 | 2019 | 21819 | 0.060 |
Why?
| | Middle Aged | 13 | 2019 | 33228 | 0.060 |
Why?
| | Proto-Oncogene Proteins | 2 | 2000 | 647 | 0.060 |
Why?
| | Gram-Negative Bacteria | 4 | 1992 | 73 | 0.060 |
Why?
| | Receptors, Interleukin-6 | 2 | 1995 | 43 | 0.060 |
Why?
| | Aging | 1 | 1995 | 1864 | 0.060 |
Why?
| | Genes, nef | 1 | 2004 | 1 | 0.060 |
Why?
| | SAIDS Vaccines | 1 | 2004 | 4 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 2 | 2017 | 2412 | 0.060 |
Why?
| | Sex Factors | 1 | 2010 | 2060 | 0.060 |
Why?
| | Libraries | 1 | 2024 | 4 | 0.060 |
Why?
| | Books | 1 | 2024 | 3 | 0.060 |
Why?
| | DNA Primers | 2 | 1995 | 514 | 0.060 |
Why?
| | Mice, Transgenic | 1 | 2009 | 2163 | 0.050 |
Why?
| | AIDS Vaccines | 1 | 2004 | 52 | 0.050 |
Why?
| | Hydrocarbons, Chlorinated | 1 | 2024 | 23 | 0.050 |
Why?
| | Alzheimer Disease | 1 | 2010 | 558 | 0.050 |
Why?
| | Severity of Illness Index | 2 | 2009 | 2822 | 0.050 |
Why?
| | Fixation, Ocular | 1 | 2004 | 21 | 0.050 |
Why?
| | Asbestos | 1 | 2024 | 37 | 0.050 |
Why?
| | Norepinephrine | 2 | 2011 | 204 | 0.050 |
Why?
| | Glycoproteins | 2 | 1996 | 342 | 0.050 |
Why?
| | Iodine Radioisotopes | 2 | 1994 | 145 | 0.050 |
Why?
| | Radioimmunoassay | 4 | 1994 | 173 | 0.050 |
Why?
| | Quinidine | 2 | 2003 | 6 | 0.050 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2024 | 132 | 0.050 |
Why?
| | Schizophrenia | 1 | 2008 | 438 | 0.050 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 1 | 2004 | 86 | 0.050 |
Why?
| | Gram-Positive Bacteria | 3 | 1992 | 48 | 0.050 |
Why?
| | Muscle Contraction | 3 | 1996 | 423 | 0.050 |
Why?
| | Odorants | 1 | 2024 | 109 | 0.050 |
Why?
| | Postoperative Complications | 2 | 2018 | 2639 | 0.050 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2006 | 251 | 0.050 |
Why?
| | Electrophysiology | 5 | 2003 | 217 | 0.050 |
Why?
| | Visual Fields | 2 | 2002 | 90 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 1998 | 858 | 0.050 |
Why?
| | Anti-Bacterial Agents | 3 | 1992 | 1797 | 0.050 |
Why?
| | Discrimination Learning | 2 | 2008 | 46 | 0.050 |
Why?
| | Serotonin Receptor Agonists | 2 | 2000 | 26 | 0.050 |
Why?
| | Pituitary Hormone-Releasing Hormones | 2 | 1994 | 10 | 0.050 |
Why?
| | Concept Formation | 1 | 2002 | 32 | 0.050 |
Why?
| | Biguanides | 2 | 2000 | 12 | 0.050 |
Why?
| | Vocabulary | 1 | 2002 | 38 | 0.050 |
Why?
| | Blotting, Western | 2 | 1995 | 1225 | 0.050 |
Why?
| | Xenopus | 3 | 2001 | 87 | 0.050 |
Why?
| | Edema | 2 | 1993 | 129 | 0.050 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 1997 | 610 | 0.050 |
Why?
| | Inflammation | 1 | 1993 | 2835 | 0.050 |
Why?
| | Adolescent Behavior | 1 | 2007 | 529 | 0.050 |
Why?
| | Natriuretic Peptides | 1 | 2022 | 9 | 0.050 |
Why?
| | Rabbits | 3 | 1993 | 792 | 0.050 |
Why?
| | Calcium Compounds | 1 | 2001 | 5 | 0.050 |
Why?
| | Atrial Natriuretic Factor | 1 | 2022 | 57 | 0.050 |
Why?
| | Mathematics | 1 | 2002 | 103 | 0.050 |
Why?
| | Spatial Behavior | 1 | 2001 | 26 | 0.050 |
Why?
| | Dopamine | 2 | 1996 | 303 | 0.050 |
Why?
| | Treatment Outcome | 4 | 2018 | 10745 | 0.050 |
Why?
| | Hypocalcemia | 1 | 2001 | 27 | 0.050 |
Why?
| | Lactates | 1 | 2001 | 85 | 0.050 |
Why?
| | Transcription, Genetic | 4 | 1997 | 1455 | 0.050 |
Why?
| | Microsurgery | 1 | 2022 | 75 | 0.050 |
Why?
| | Prevalence | 3 | 2019 | 2710 | 0.040 |
Why?
| | Signal Transduction | 5 | 2001 | 5076 | 0.040 |
Why?
| | Sequence Alignment | 2 | 1999 | 342 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2004 | 789 | 0.040 |
Why?
| | Ion Channels | 1 | 2001 | 133 | 0.040 |
Why?
| | Tritium | 2 | 2000 | 76 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 2 | 1999 | 134 | 0.040 |
Why?
| | Cell Membrane | 2 | 1994 | 735 | 0.040 |
Why?
| | Neurons | 4 | 1997 | 1587 | 0.040 |
Why?
| | Calcium Channels | 1 | 2001 | 159 | 0.040 |
Why?
| | Acute-Phase Proteins | 2 | 1997 | 67 | 0.040 |
Why?
| | Mesoderm | 1 | 2001 | 144 | 0.040 |
Why?
| | Predictive Value of Tests | 3 | 2011 | 2022 | 0.040 |
Why?
| | Radioligand Assay | 2 | 2000 | 48 | 0.040 |
Why?
| | Imagination | 1 | 2000 | 18 | 0.040 |
Why?
| | Hormone Antagonists | 2 | 1997 | 34 | 0.040 |
Why?
| | Tetraethylammonium | 1 | 1999 | 16 | 0.040 |
Why?
| | Receptors, Eph Family | 1 | 1999 | 6 | 0.040 |
Why?
| | DNA | 3 | 1995 | 1458 | 0.040 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 1999 | 21 | 0.040 |
Why?
| | Vasodilator Agents | 1 | 2022 | 331 | 0.040 |
Why?
| | Evolution, Molecular | 2 | 2008 | 488 | 0.040 |
Why?
| | DNA-Binding Proteins | 2 | 1997 | 1501 | 0.040 |
Why?
| | 3,4-Dihydroxyphenylacetic Acid | 2 | 1996 | 19 | 0.040 |
Why?
| | Receptor, EphB4 | 1 | 1999 | 34 | 0.040 |
Why?
| | Phylogeny | 2 | 2003 | 903 | 0.040 |
Why?
| | Immunoblotting | 2 | 1997 | 306 | 0.040 |
Why?
| | GTP-Binding Proteins | 2 | 1999 | 161 | 0.040 |
Why?
| | Cytoskeleton | 1 | 2000 | 188 | 0.040 |
Why?
| | Cystadenocarcinoma, Papillary | 1 | 1999 | 5 | 0.040 |
Why?
| | Ovariectomy | 2 | 1996 | 152 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2022 | 333 | 0.040 |
Why?
| | Infant | 5 | 2018 | 9395 | 0.040 |
Why?
| | Uterine Contraction | 1 | 1999 | 17 | 0.040 |
Why?
| | Fallopian Tube Neoplasms | 1 | 1999 | 17 | 0.040 |
Why?
| | Postpartum Period | 2 | 1999 | 337 | 0.040 |
Why?
| | Mice, Inbred C57BL | 1 | 2009 | 5749 | 0.040 |
Why?
| | Eosinophils | 1 | 2001 | 332 | 0.040 |
Why?
| | Enoyl-CoA Hydratase | 1 | 1998 | 12 | 0.040 |
Why?
| | Monocytes | 1 | 2001 | 563 | 0.040 |
Why?
| | Antigens, CD | 1 | 2001 | 521 | 0.040 |
Why?
| | Glycoprotein Hormones, alpha Subunit | 1 | 1998 | 23 | 0.040 |
Why?
| | Fibroblast Growth Factor 9 | 1 | 1998 | 2 | 0.040 |
Why?
| | Research | 1 | 2001 | 448 | 0.040 |
Why?
| | Spodoptera | 1 | 1998 | 40 | 0.040 |
Why?
| | Progestins | 1 | 1998 | 78 | 0.040 |
Why?
| | Muscle, Smooth | 2 | 1996 | 155 | 0.040 |
Why?
| | Actins | 1 | 2000 | 416 | 0.040 |
Why?
| | Binding Sites | 3 | 1999 | 1301 | 0.040 |
Why?
| | Retrospective Studies | 4 | 2019 | 15504 | 0.040 |
Why?
| | Baculoviridae | 1 | 1998 | 44 | 0.040 |
Why?
| | Adenoma | 1 | 2000 | 230 | 0.040 |
Why?
| | Antibody Specificity | 2 | 1997 | 189 | 0.040 |
Why?
| | Serotonin | 1 | 2000 | 323 | 0.040 |
Why?
| | Photic Stimulation | 2 | 2018 | 241 | 0.040 |
Why?
| | Carcinoma, Embryonal | 1 | 1997 | 3 | 0.030 |
Why?
| | Adipose Tissue, Brown | 1 | 1998 | 53 | 0.030 |
Why?
| | Membrane Proteins | 2 | 2001 | 1163 | 0.030 |
Why?
| | Species Specificity | 2 | 1996 | 586 | 0.030 |
Why?
| | Peptones | 1 | 1997 | 1 | 0.030 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 1999 | 234 | 0.030 |
Why?
| | Medroxyprogesterone Acetate | 2 | 1998 | 36 | 0.030 |
Why?
| | Gastric Acid | 1 | 1997 | 14 | 0.030 |
Why?
| | Drainage | 1 | 2018 | 171 | 0.030 |
Why?
| | Endothelin-1 | 1 | 1999 | 182 | 0.030 |
Why?
| | Lymphokines | 1 | 1997 | 131 | 0.030 |
Why?
| | Placental Lactogen | 1 | 1997 | 23 | 0.030 |
Why?
| | Pulmonary Veins | 1 | 2018 | 99 | 0.030 |
Why?
| | Neurosecretory Systems | 1 | 1997 | 32 | 0.030 |
Why?
| | Vaginal Neoplasms | 1 | 1996 | 18 | 0.030 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 1996 | 16 | 0.030 |
Why?
| | Tissue Polypeptide Antigen | 1 | 1996 | 2 | 0.030 |
Why?
| | Oligopeptides | 2 | 1999 | 271 | 0.030 |
Why?
| | Culture Media, Conditioned | 1 | 1997 | 110 | 0.030 |
Why?
| | Leiomyoma | 1 | 1997 | 77 | 0.030 |
Why?
| | Depression, Chemical | 1 | 1996 | 23 | 0.030 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 1996 | 59 | 0.030 |
Why?
| | Phenylurea Compounds | 1 | 1997 | 96 | 0.030 |
Why?
| | Uterine Neoplasms | 1 | 1997 | 109 | 0.030 |
Why?
| | Deoxyglucose | 1 | 1996 | 53 | 0.030 |
Why?
| | Oxytocin | 1 | 1996 | 51 | 0.030 |
Why?
| | Glucose Transporter Type 1 | 1 | 1996 | 50 | 0.030 |
Why?
| | Cytoplasm | 1 | 1997 | 272 | 0.030 |
Why?
| | Molecular Structure | 1 | 1997 | 489 | 0.030 |
Why?
| | Membrane Potentials | 4 | 2001 | 284 | 0.030 |
Why?
| | Neoplasm Staging | 2 | 1998 | 1371 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 1998 | 378 | 0.030 |
Why?
| | Trophoblasts | 1 | 1998 | 199 | 0.030 |
Why?
| | Potassium Channels, Inwardly Rectifying | 1 | 1996 | 38 | 0.030 |
Why?
| | Carcinoma | 1 | 1998 | 238 | 0.030 |
Why?
| | Coenzyme A Ligases | 1 | 1995 | 13 | 0.030 |
Why?
| | Immune Sera | 1 | 1995 | 88 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1055 | 0.030 |
Why?
| | Platelet Activating Factor | 1 | 1995 | 76 | 0.030 |
Why?
| | Submandibular Gland | 1 | 1995 | 20 | 0.030 |
Why?
| | Piperazines | 2 | 2000 | 350 | 0.030 |
Why?
| | Theophylline | 1 | 1995 | 67 | 0.030 |
Why?
| | Receptors, Serotonin, 5-HT3 | 3 | 2000 | 15 | 0.030 |
Why?
| | Meta-Analysis as Topic | 1 | 2016 | 186 | 0.030 |
Why?
| | Genetic Heterogeneity | 1 | 1995 | 59 | 0.030 |
Why?
| | Restriction Mapping | 1 | 1995 | 77 | 0.030 |
Why?
| | Azepines | 2 | 2010 | 90 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 1998 | 434 | 0.030 |
Why?
| | Lipoprotein Lipase | 1 | 1995 | 59 | 0.030 |
Why?
| | Brain Chemistry | 1 | 1995 | 116 | 0.030 |
Why?
| | Biological Transport | 1 | 1996 | 416 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 1995 | 269 | 0.030 |
Why?
| | Gastric Mucosa | 1 | 1995 | 55 | 0.030 |
Why?
| | Thyrotropin-Releasing Hormone | 3 | 1997 | 10 | 0.030 |
Why?
| | Protein Biosynthesis | 1 | 1997 | 430 | 0.030 |
Why?
| | Cystadenocarcinoma, Mucinous | 1 | 1994 | 13 | 0.030 |
Why?
| | Infertility, Male | 2 | 1985 | 61 | 0.030 |
Why?
| | Molecular Chaperones | 1 | 1996 | 195 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 307 | 0.030 |
Why?
| | Salivary Glands | 1 | 1994 | 33 | 0.030 |
Why?
| | Inhibins | 1 | 1994 | 44 | 0.030 |
Why?
| | Receptor, Cholecystokinin B | 1 | 1994 | 1 | 0.030 |
Why?
| | Vibration | 2 | 1988 | 70 | 0.030 |
Why?
| | Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1994 | 14 | 0.030 |
Why?
| | Gastrins | 1 | 1994 | 8 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 851 | 0.030 |
Why?
| | Gestational Age | 1 | 1997 | 902 | 0.030 |
Why?
| | Haplorhini | 1 | 1994 | 52 | 0.030 |
Why?
| | Embolization, Therapeutic | 1 | 1996 | 229 | 0.030 |
Why?
| | HTLV-I Infections | 1 | 1994 | 24 | 0.030 |
Why?
| | Eye Infections, Viral | 1 | 1994 | 9 | 0.030 |
Why?
| | RNA-Directed DNA Polymerase | 1 | 1994 | 34 | 0.030 |
Why?
| | Cystadenocarcinoma, Serous | 1 | 1994 | 75 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 1996 | 480 | 0.030 |
Why?
| | Receptors, Fibroblast Growth Factor | 1 | 1994 | 66 | 0.030 |
Why?
| | Bronchodilator Agents | 1 | 1995 | 247 | 0.030 |
Why?
| | Pleurisy | 1 | 1993 | 5 | 0.030 |
Why?
| | Vestibular Nuclei | 1 | 1973 | 7 | 0.030 |
Why?
| | Hydrolysis | 1 | 1994 | 176 | 0.030 |
Why?
| | Trachea | 1 | 1995 | 237 | 0.030 |
Why?
| | Ear, External | 1 | 1993 | 21 | 0.030 |
Why?
| | Receptors, Estrogen | 1 | 1996 | 436 | 0.030 |
Why?
| | Posture | 2 | 1988 | 186 | 0.030 |
Why?
| | Lipoxygenase Inhibitors | 1 | 1993 | 37 | 0.030 |
Why?
| | Neuropeptides | 1 | 1993 | 73 | 0.030 |
Why?
| | Survival Rate | 1 | 2018 | 1963 | 0.030 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 1993 | 79 | 0.030 |
Why?
| | Cardiac Conduction System Disease | 1 | 2013 | 3 | 0.030 |
Why?
| | Neurotransmitter Uptake Inhibitors | 1 | 1993 | 2 | 0.030 |
Why?
| | Reference Values | 2 | 1997 | 816 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 1997 | 886 | 0.030 |
Why?
| | Gestrinone | 1 | 1992 | 1 | 0.030 |
Why?
| | Extracellular Space | 1 | 1993 | 119 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2018 | 785 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 1994 | 232 | 0.030 |
Why?
| | Cerebral Ventricles | 1 | 1993 | 52 | 0.030 |
Why?
| | Receptors, Cell Surface | 2 | 1985 | 382 | 0.030 |
Why?
| | Down-Regulation | 1 | 1995 | 656 | 0.030 |
Why?
| | Child, Preschool | 6 | 2011 | 10997 | 0.020 |
Why?
| | Mice, Nude | 1 | 1994 | 696 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2001 | 1993 | 0.020 |
Why?
| | Cyclic AMP | 1 | 1993 | 234 | 0.020 |
Why?
| | Mothers | 1 | 2019 | 752 | 0.020 |
Why?
| | Therapy, Computer-Assisted | 1 | 2013 | 62 | 0.020 |
Why?
| | Androgen-Insensitivity Syndrome | 2 | 1985 | 4 | 0.020 |
Why?
| | Uveitis | 1 | 1994 | 134 | 0.020 |
Why?
| | Myocardium | 1 | 1998 | 1001 | 0.020 |
Why?
| | Cefmenoxime | 1 | 1992 | 1 | 0.020 |
Why?
| | Energy Intake | 1 | 1995 | 484 | 0.020 |
Why?
| | Phospholipids | 1 | 1994 | 222 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2014 | 337 | 0.020 |
Why?
| | Triglycerides | 1 | 1994 | 524 | 0.020 |
Why?
| | Isoflavones | 1 | 2012 | 26 | 0.020 |
Why?
| | Apoptosis | 2 | 2001 | 2551 | 0.020 |
Why?
| | Cell Division | 1 | 1993 | 796 | 0.020 |
Why?
| | Weight Gain | 1 | 1995 | 519 | 0.020 |
Why?
| | Dihydrotestosterone | 2 | 1996 | 44 | 0.020 |
Why?
| | Social Control, Informal | 1 | 2011 | 21 | 0.020 |
Why?
| | Placebos | 1 | 2012 | 199 | 0.020 |
Why?
| | Death, Sudden, Cardiac | 1 | 2013 | 185 | 0.020 |
Why?
| | Genetics, Behavioral | 1 | 2011 | 36 | 0.020 |
Why?
| | Proteins | 1 | 1997 | 1008 | 0.020 |
Why?
| | Central Venous Pressure | 1 | 2011 | 14 | 0.020 |
Why?
| | Pain | 1 | 1997 | 754 | 0.020 |
Why?
| | Peptides, Cyclic | 1 | 1993 | 259 | 0.020 |
Why?
| | Equipment Design | 1 | 2013 | 521 | 0.020 |
Why?
| | Renin | 1 | 2011 | 35 | 0.020 |
Why?
| | Arginine Vasopressin | 1 | 2011 | 44 | 0.020 |
Why?
| | Models, Genetic | 1 | 2014 | 599 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 1994 | 512 | 0.020 |
Why?
| | Ovary | 1 | 1992 | 221 | 0.020 |
Why?
| | Stroop Test | 1 | 2010 | 24 | 0.020 |
Why?
| | Flurbiprofen | 1 | 2010 | 3 | 0.020 |
Why?
| | Sheep | 1 | 1993 | 856 | 0.020 |
Why?
| | Testis | 3 | 1985 | 151 | 0.020 |
Why?
| | Cell Differentiation | 2 | 1997 | 1982 | 0.020 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2010 | 29 | 0.020 |
Why?
| | Hyperprolactinemia | 1 | 1990 | 5 | 0.020 |
Why?
| | Prolactinoma | 1 | 1990 | 13 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 530 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2014 | 1507 | 0.020 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2010 | 66 | 0.020 |
Why?
| | Taurine | 1 | 2010 | 46 | 0.020 |
Why?
| | Dermatologic Agents | 2 | 2009 | 69 | 0.020 |
Why?
| | Ovarian Diseases | 1 | 1989 | 12 | 0.020 |
Why?
| | Gene Deletion | 2 | 2004 | 389 | 0.020 |
Why?
| | Pituitary Diseases | 1 | 1989 | 20 | 0.020 |
Why?
| | Hypothalamic Diseases | 1 | 1989 | 18 | 0.020 |
Why?
| | Risk Factors | 2 | 2017 | 10325 | 0.020 |
Why?
| | Sensitivity and Specificity | 2 | 2009 | 1935 | 0.020 |
Why?
| | HIV Infections | 1 | 2004 | 2828 | 0.020 |
Why?
| | Alanine | 1 | 2010 | 152 | 0.020 |
Why?
| | Environment | 1 | 2011 | 357 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 1996 | 938 | 0.020 |
Why?
| | Neural Pathways | 1 | 2011 | 295 | 0.020 |
Why?
| | Electric Conductivity | 2 | 2002 | 86 | 0.020 |
Why?
| | Infertility, Female | 1 | 1990 | 108 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 2010 | 5106 | 0.020 |
Why?
| | Color | 1 | 2009 | 77 | 0.020 |
Why?
| | Calibration | 1 | 2009 | 146 | 0.020 |
Why?
| | Photography | 1 | 2009 | 95 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2011 | 888 | 0.020 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 1 | 2009 | 62 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 1022 | 0.020 |
Why?
| | Protein Binding | 1 | 1994 | 2216 | 0.020 |
Why?
| | Cyclosporine | 1 | 2009 | 268 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2011 | 695 | 0.020 |
Why?
| | Intelligence Tests | 1 | 2007 | 57 | 0.020 |
Why?
| | Schizophrenic Psychology | 1 | 2008 | 94 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2011 | 1261 | 0.020 |
Why?
| | Estrogens, Conjugated (USP) | 2 | 1978 | 49 | 0.020 |
Why?
| | Kidney | 1 | 1995 | 1467 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2012 | 559 | 0.020 |
Why?
| | Neurons, Afferent | 1 | 1988 | 97 | 0.020 |
Why?
| | Janus Kinase 1 | 2 | 1997 | 24 | 0.020 |
Why?
| | Injections, Intravenous | 2 | 2004 | 207 | 0.020 |
Why?
| | Organ Size | 1 | 2008 | 477 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2012 | 1981 | 0.020 |
Why?
| | Protein Kinase C | 2 | 1999 | 261 | 0.020 |
Why?
| | Foot | 1 | 1988 | 97 | 0.020 |
Why?
| | Bromocriptine | 2 | 1990 | 29 | 0.020 |
Why?
| | Antigens, Neoplasm | 1 | 1989 | 319 | 0.020 |
Why?
| | Pilot Projects | 1 | 2012 | 1692 | 0.020 |
Why?
| | Enzyme Activation | 2 | 1999 | 810 | 0.020 |
Why?
| | Faculty | 1 | 2007 | 145 | 0.020 |
Why?
| | Cystectomy | 1 | 2006 | 37 | 0.020 |
Why?
| | Menotropins | 1 | 1985 | 2 | 0.020 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2006 | 58 | 0.020 |
Why?
| | Preoperative Care | 2 | 1999 | 356 | 0.020 |
Why?
| | Thalamic Nuclei | 2 | 1984 | 10 | 0.020 |
Why?
| | Progesterone | 3 | 1996 | 254 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2006 | 303 | 0.020 |
Why?
| | Aged | 5 | 2006 | 23794 | 0.010 |
Why?
| | Molecular Weight | 2 | 1996 | 335 | 0.010 |
Why?
| | Alleles | 1 | 2008 | 890 | 0.010 |
Why?
| | Models, Biological | 2 | 2003 | 1773 | 0.010 |
Why?
| | Behavior, Animal | 1 | 2008 | 497 | 0.010 |
Why?
| | Neutralization Tests | 1 | 2004 | 75 | 0.010 |
Why?
| | HIV Antibodies | 1 | 2004 | 62 | 0.010 |
Why?
| | Cats | 4 | 1984 | 209 | 0.010 |
Why?
| | Vaccines, Synthetic | 1 | 2004 | 126 | 0.010 |
Why?
| | CD4 Lymphocyte Count | 1 | 2004 | 269 | 0.010 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2004 | 88 | 0.010 |
Why?
| | Macaca mulatta | 1 | 2004 | 166 | 0.010 |
Why?
| | Vaccines, Attenuated | 1 | 2004 | 131 | 0.010 |
Why?
| | Comorbidity | 1 | 2009 | 1614 | 0.010 |
Why?
| | Phosphorylation | 2 | 1999 | 1758 | 0.010 |
Why?
| | Propafenone | 1 | 2003 | 2 | 0.010 |
Why?
| | Barium | 1 | 2003 | 26 | 0.010 |
Why?
| | Quinine | 1 | 2003 | 20 | 0.010 |
Why?
| | Ethanolamines | 1 | 2003 | 17 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 2004 | 200 | 0.010 |
Why?
| | Glyburide | 1 | 2003 | 32 | 0.010 |
Why?
| | Lidocaine | 1 | 2003 | 42 | 0.010 |
Why?
| | HIV | 1 | 2004 | 234 | 0.010 |
Why?
| | Biopsy | 1 | 2006 | 1124 | 0.010 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2003 | 114 | 0.010 |
Why?
| | Docosahexaenoic Acids | 1 | 2003 | 84 | 0.010 |
Why?
| | Viral Load | 1 | 2004 | 464 | 0.010 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2003 | 159 | 0.010 |
Why?
| | Delayed Rectifier Potassium Channels | 1 | 2002 | 9 | 0.010 |
Why?
| | Lymphocytes | 1 | 2004 | 393 | 0.010 |
Why?
| | Shab Potassium Channels | 1 | 2002 | 18 | 0.010 |
Why?
| | Protein Kinase Inhibitors | 2 | 1999 | 916 | 0.010 |
Why?
| | NAD+ Nucleosidase | 1 | 2001 | 3 | 0.010 |
Why?
| | ADP-ribosyl Cyclase | 1 | 2001 | 5 | 0.010 |
Why?
| | Adenosine Diphosphate Ribose | 1 | 2001 | 7 | 0.010 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2003 | 124 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2003 | 560 | 0.010 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2001 | 38 | 0.010 |
Why?
| | Prognosis | 1 | 2010 | 4013 | 0.010 |
Why?
| | Fetal Proteins | 1 | 2001 | 17 | 0.010 |
Why?
| | Antigens, Differentiation | 1 | 2001 | 83 | 0.010 |
Why?
| | Jurkat Cells | 1 | 2001 | 134 | 0.010 |
Why?
| | Risk Assessment | 1 | 2011 | 3432 | 0.010 |
Why?
| | Aptitude Tests | 1 | 2001 | 4 | 0.010 |
Why?
| | Perciformes | 1 | 2001 | 18 | 0.010 |
Why?
| | Muscle Spindles | 1 | 1981 | 6 | 0.010 |
Why?
| | Clomiphene | 1 | 1981 | 15 | 0.010 |
Why?
| | Twin Studies as Topic | 1 | 2001 | 19 | 0.010 |
Why?
| | NAD | 1 | 2001 | 77 | 0.010 |
Why?
| | Lung | 1 | 2014 | 4062 | 0.010 |
Why?
| | Amenorrhea | 1 | 1981 | 27 | 0.010 |
Why?
| | Protein Subunits | 1 | 2002 | 239 | 0.010 |
Why?
| | Ovulation Induction | 1 | 1981 | 56 | 0.010 |
Why?
| | Phalloidine | 1 | 2000 | 2 | 0.010 |
Why?
| | Cytochalasin B | 1 | 2000 | 17 | 0.010 |
Why?
| | TRPM Cation Channels | 1 | 2001 | 74 | 0.010 |
Why?
| | Stimulation, Chemical | 1 | 2000 | 59 | 0.010 |
Why?
| | Kruppel-Like Factor 6 | 1 | 2000 | 1 | 0.010 |
Why?
| | Tubocurarine | 1 | 2000 | 4 | 0.010 |
Why?
| | T-Box Domain Proteins | 1 | 2001 | 98 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2003 | 860 | 0.010 |
Why?
| | Ondansetron | 1 | 2000 | 16 | 0.010 |
Why?
| | RNA, Viral | 1 | 2004 | 654 | 0.010 |
Why?
| | Skin | 1 | 1985 | 751 | 0.010 |
Why?
| | Serotonin Antagonists | 1 | 2000 | 32 | 0.010 |
Why?
| | Spinal Cord | 1 | 2003 | 370 | 0.010 |
Why?
| | Ferrets | 1 | 2000 | 27 | 0.010 |
Why?
| | Antibodies, Viral | 1 | 2004 | 624 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2008 | 2184 | 0.010 |
Why?
| | Fibroblasts | 1 | 1985 | 993 | 0.010 |
Why?
| | Exocytosis | 1 | 2000 | 89 | 0.010 |
Why?
| | Fatty Acids | 1 | 2003 | 442 | 0.010 |
Why?
| | Cerebellar Nuclei | 1 | 1980 | 10 | 0.010 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2000 | 66 | 0.010 |
Why?
| | Actin Cytoskeleton | 1 | 2000 | 101 | 0.010 |
Why?
| | Biomarkers | 1 | 2011 | 4144 | 0.010 |
Why?
| | Clinical Protocols | 1 | 2001 | 267 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2000 | 324 | 0.010 |
Why?
| | Ritodrine | 1 | 1999 | 1 | 0.010 |
Why?
| | Son of Sevenless Proteins | 1 | 1999 | 4 | 0.010 |
Why?
| | Virulence Factors, Bordetella | 1 | 1999 | 20 | 0.010 |
Why?
| | Pertussis Toxin | 1 | 1999 | 26 | 0.010 |
Why?
| | Imidazoles | 1 | 2000 | 238 | 0.010 |
Why?
| | Endothelin Receptor Antagonists | 1 | 1999 | 62 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 2001 | 487 | 0.010 |
Why?
| | Receptor, Endothelin A | 1 | 1999 | 65 | 0.010 |
Why?
| | Ion Transport | 1 | 1999 | 60 | 0.010 |
Why?
| | Cations | 1 | 1999 | 84 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 2001 | 500 | 0.010 |
Why?
| | Permeability | 1 | 1999 | 161 | 0.010 |
Why?
| | Zebrafish Proteins | 1 | 2001 | 286 | 0.010 |
Why?
| | Hemolytic Plaque Technique | 1 | 1997 | 29 | 0.010 |
Why?
| | Secretory Rate | 1 | 1997 | 16 | 0.010 |
Why?
| | Postural Balance | 1 | 1981 | 216 | 0.010 |
Why?
| | Oocytes | 1 | 1999 | 180 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 1997 | 45 | 0.010 |
Why?
| | Prospective Studies | 1 | 2010 | 7572 | 0.010 |
Why?
| | Cervix Uteri | 1 | 1998 | 48 | 0.010 |
Why?
| | MAP Kinase Kinase 2 | 1 | 1997 | 28 | 0.010 |
Why?
| | Endometrium | 1 | 1998 | 58 | 0.010 |
Why?
| | Gadolinium DTPA | 1 | 1998 | 70 | 0.010 |
Why?
| | Leukemia Inhibitory Factor | 1 | 1997 | 6 | 0.010 |
Why?
| | Myometrium | 1 | 1998 | 39 | 0.010 |
Why?
| | MAP Kinase Kinase 1 | 1 | 1997 | 75 | 0.010 |
Why?
| | Pentagastrin | 1 | 1997 | 3 | 0.010 |
Why?
| | Devazepide | 1 | 1997 | 3 | 0.010 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 1998 | 161 | 0.010 |
Why?
| | Famotidine | 1 | 1997 | 2 | 0.010 |
Why?
| | Atropine | 1 | 1997 | 23 | 0.010 |
Why?
| | Benzodiazepinones | 1 | 1997 | 17 | 0.010 |
Why?
| | Colorado | 1 | 2007 | 4515 | 0.010 |
Why?
| | Pituitary Gland, Posterior | 1 | 1997 | 2 | 0.010 |
Why?
| | Methacholine Chloride | 1 | 1997 | 52 | 0.010 |
Why?
| | Genes, ras | 1 | 1997 | 97 | 0.010 |
Why?
| | Janus Kinase 2 | 1 | 1997 | 32 | 0.010 |
Why?
| | Colchicine | 1 | 1997 | 23 | 0.010 |
Why?
| | Injections, Intraventricular | 1 | 1997 | 55 | 0.010 |
Why?
| | Muscarinic Antagonists | 1 | 1997 | 29 | 0.010 |
Why?
| | STAT1 Transcription Factor | 1 | 1997 | 73 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2000 | 809 | 0.010 |
Why?
| | Luciferases | 1 | 1997 | 149 | 0.010 |
Why?
| | Histamine | 1 | 1997 | 67 | 0.010 |
Why?
| | Indoles | 1 | 2000 | 410 | 0.010 |
Why?
| | Chemokine CXCL1 | 1 | 1997 | 76 | 0.010 |
Why?
| | Clusterin | 1 | 1996 | 11 | 0.010 |
Why?
| | Histamine H2 Antagonists | 1 | 1997 | 30 | 0.010 |
Why?
| | Tyrosine | 1 | 1997 | 222 | 0.010 |
Why?
| | Gene Transfer Techniques | 1 | 1998 | 169 | 0.010 |
Why?
| | Psychometrics | 1 | 2001 | 720 | 0.010 |
Why?
| | Stomach | 1 | 1997 | 110 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2004 | 2475 | 0.010 |
Why?
| | Formaldehyde | 1 | 1997 | 63 | 0.010 |
Why?
| | Stereoisomerism | 1 | 1996 | 96 | 0.010 |
Why?
| | G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 1996 | 10 | 0.010 |
Why?
| | Seizures | 1 | 1980 | 425 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2006 | 2667 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 1999 | 664 | 0.010 |
Why?
| | Neoplasm Invasiveness | 1 | 1998 | 507 | 0.010 |
Why?
| | ROC Curve | 1 | 1998 | 545 | 0.010 |
Why?
| | Leptin | 1 | 1997 | 236 | 0.010 |
Why?
| | Vaccination | 1 | 2004 | 1377 | 0.010 |
Why?
| | Dogs | 1 | 1997 | 411 | 0.010 |
Why?
| | Chorionic Gonadotropin | 1 | 1976 | 80 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1996 | 432 | 0.010 |
Why?
| | Conjugation, Genetic | 1 | 1975 | 5 | 0.010 |
Why?
| | Glucosamine | 1 | 1975 | 13 | 0.010 |
Why?
| | Mannose | 1 | 1975 | 24 | 0.010 |
Why?
| | Electric Stimulation | 2 | 1973 | 264 | 0.010 |
Why?
| | Receptors, FSH | 2 | 1985 | 9 | 0.010 |
Why?
| | Ciliophora | 1 | 1975 | 15 | 0.010 |
Why?
| | STAT3 Transcription Factor | 1 | 1997 | 206 | 0.010 |
Why?
| | Chlorides | 1 | 1996 | 136 | 0.010 |
Why?
| | Dendrites | 1 | 1996 | 105 | 0.010 |
Why?
| | Activins | 1 | 1994 | 28 | 0.010 |
Why?
| | Growth Hormone-Releasing Hormone | 1 | 1994 | 24 | 0.010 |
Why?
| | Contrast Media | 1 | 1998 | 462 | 0.010 |
Why?
| | Polycystic Ovary Syndrome | 1 | 1977 | 176 | 0.010 |
Why?
| | Cross-Cultural Comparison | 1 | 1995 | 87 | 0.010 |
Why?
| | Dexamethasone | 1 | 1996 | 368 | 0.010 |
Why?
| | Adenosine | 1 | 1996 | 225 | 0.010 |
Why?
| | gamma-Aminobutyric Acid | 1 | 1996 | 198 | 0.010 |
Why?
| | Eating | 1 | 1997 | 379 | 0.010 |
Why?
| | Axons | 1 | 1996 | 198 | 0.010 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 1994 | 68 | 0.010 |
Why?
| | HTLV-I Antibodies | 1 | 1994 | 6 | 0.010 |
Why?
| | Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 1993 | 3 | 0.010 |
Why?
| | Vasoactive Intestinal Peptide | 1 | 1993 | 11 | 0.010 |
Why?
| | Human T-lymphotropic virus 1 | 1 | 1994 | 28 | 0.010 |
Why?
| | Cytosol | 1 | 1994 | 226 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2004 | 4282 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 1996 | 1269 | 0.010 |
Why?
| | Muscles | 2 | 1988 | 325 | 0.010 |
Why?
| | Estrogens | 1 | 1996 | 367 | 0.010 |
Why?
| | Natural Language Processing | 1 | 1995 | 94 | 0.010 |
Why?
| | Seroepidemiologic Studies | 1 | 1994 | 165 | 0.010 |
Why?
| | Benztropine | 1 | 1993 | 2 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 1998 | 1249 | 0.010 |
Why?
| | Organ Specificity | 1 | 1994 | 304 | 0.010 |
Why?
| | Infusions, Parenteral | 1 | 1993 | 40 | 0.010 |
Why?
| | Dopamine Antagonists | 1 | 1993 | 27 | 0.010 |
Why?
| | Gonadotropins, Equine | 1 | 1992 | 2 | 0.010 |
Why?
| | 3-Hydroxysteroid Dehydrogenases | 1 | 1992 | 8 | 0.010 |
Why?
| | Hypophysectomy | 1 | 1992 | 15 | 0.010 |
Why?
| | Aldehyde-Lyases | 1 | 1992 | 3 | 0.010 |
Why?
| | Steroid 17-alpha-Hydroxylase | 1 | 1992 | 5 | 0.010 |
Why?
| | 17-Hydroxysteroid Dehydrogenases | 1 | 1992 | 5 | 0.010 |
Why?
| | Visual Cortex | 1 | 1973 | 70 | 0.010 |
Why?
| | Aromatase | 1 | 1992 | 32 | 0.010 |
Why?
| | Electromyography | 2 | 1988 | 401 | 0.010 |
Why?
| | beta-Lactamases | 1 | 1992 | 48 | 0.010 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1992 | 155 | 0.010 |
Why?
| | Synapses | 1 | 1996 | 427 | 0.010 |
Why?
| | Oligodendroglia | 1 | 1994 | 178 | 0.010 |
Why?
| | Cortical Spreading Depression | 1 | 1971 | 9 | 0.010 |
Why?
| | Amino Acids | 1 | 1975 | 497 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1997 | 2486 | 0.010 |
Why?
| | Androgens | 1 | 1992 | 187 | 0.010 |
Why?
| | Epithelial Cells | 1 | 1996 | 1094 | 0.010 |
Why?
| | Neuroglia | 1 | 1971 | 173 | 0.010 |
Why?
| | Bacterial Infections | 1 | 1992 | 250 | 0.010 |
Why?
| | Monitoring, Immunologic | 1 | 1989 | 23 | 0.000 |
Why?
| | Carcinoembryonic Antigen | 1 | 1989 | 39 | 0.000 |
Why?
| | Dermoid Cyst | 1 | 1989 | 15 | 0.000 |
Why?
| | Visual Pathways | 2 | 1984 | 55 | 0.000 |
Why?
| | Mutation | 1 | 1999 | 3946 | 0.000 |
Why?
| | Testosterone | 2 | 1984 | 401 | 0.000 |
Why?
| | Incidence | 1 | 1994 | 2792 | 0.000 |
Why?
| | Methoxyflurane | 1 | 1966 | 2 | 0.000 |
Why?
| | RNA | 1 | 1993 | 921 | 0.000 |
Why?
| | Acid-Base Equilibrium | 1 | 1966 | 28 | 0.000 |
Why?
| | Gonadal Dysgenesis | 1 | 1985 | 7 | 0.000 |
Why?
| | Turner Syndrome | 1 | 1985 | 53 | 0.000 |
Why?
| | Hypothermia, Induced | 1 | 1966 | 79 | 0.000 |
Why?
| | Ischemia | 1 | 1988 | 407 | 0.000 |
Why?
| | Spermatogenesis | 1 | 1984 | 67 | 0.000 |
Why?
| | Obesity | 1 | 1997 | 2982 | 0.000 |
Why?
| | Evoked Potentials, Visual | 1 | 1984 | 35 | 0.000 |
Why?
| | Superior Colliculi | 1 | 1984 | 40 | 0.000 |
Why?
| | Half-Life | 1 | 1983 | 164 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1994 | 7585 | 0.000 |
Why?
| | Reflex, Stretch | 1 | 1981 | 10 | 0.000 |
Why?
| | Mechanoreceptors | 1 | 1981 | 17 | 0.000 |
Why?
| | Brain Mapping | 1 | 1984 | 504 | 0.000 |
Why?
| | Achilles Tendon | 1 | 1981 | 32 | 0.000 |
Why?
| | Penicillin G | 1 | 1980 | 7 | 0.000 |
Why?
| | Nerve Block | 1 | 1981 | 73 | 0.000 |
Why?
| | Cerebellar Cortex | 1 | 1980 | 21 | 0.000 |
Why?
| | Purkinje Cells | 1 | 1980 | 70 | 0.000 |
Why?
| | Leg | 1 | 1981 | 236 | 0.000 |
Why?
| | Drug Therapy, Combination | 1 | 1981 | 1062 | 0.000 |
Why?
| | Antibiotics, Antitubercular | 1 | 1956 | 37 | 0.000 |
Why?
| | Neoplasms, Experimental | 1 | 1956 | 176 | 0.000 |
Why?
| | Geniculate Bodies | 1 | 1973 | 20 | 0.000 |
Why?
| | Potassium | 1 | 1971 | 147 | 0.000 |
Why?
| | Chromatography, Gas | 1 | 1966 | 33 | 0.000 |
Why?
| | Plethysmography | 1 | 1966 | 106 | 0.000 |
Why?
| | Antineoplastic Agents | 1 | 1956 | 2122 | 0.000 |
Why?
| | Brain Diseases | 1 | 1966 | 141 | 0.000 |
Why?
| | Cardiovascular Diseases | 1 | 1966 | 2104 | 0.000 |
Why?
|
|
Miyake's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|